Literature DB >> 8828633

Decreased bone mineralization in children with phenylketonuria under treatment.

L Hillman1, C Schlotzhauer, D Lee, J Grasela, S Witter, S Allen, R Hillman.   

Abstract

Children with phenylketonuria (PKU) obtain a great deal of their protein and mineral intakes from synthetic elemental formulae devoid of phenylalanine. To assess the effect of such diets and/or the disease on bone mineralization, children with PKU were compared to normal children for many parameters of mineral homeostasis and bone mineralization. A total of 11 children with PKU of mean age 10.9 +/- 4.2 years were compared to a large group of normal control children mean age 11.4 +/- 4.2, and an age and sex matched subset (n = 11). Children with PKU had lower serum calcium (9.1 +/- 0.9 vs 10.4 +/- 1.9 mg/dl P < 0.01) amd magnesium (1.67 +/- 1.4 vs 2.07 +/- 0.16 mg/ dl, P < 0.001) but normal values for phosphorus, zinc, and copper. The percentage tubular reabsorption of phosphorus was increased in PKU (93 +/- 3% vs 88 +/- 6%, P < 0.05) suggesting a lower phosphorus intake and/or absorption. Serum 25-hydroxyvitamin D, parathyroid hormone and 1,25 dihydroxyvitamin D were similar in PKU and control children. Serum albumin and lean body mass by dual energy X-ray absorption were not different suggesting that protein intake was adequate. In the 11 pairs, a decreased bone mineral density was seen for the lumbar spine (0.61 +/- 0.15 vs 0.72 +/- 0.24 P < 0.05), and lower extremities (1.56 +/- 0.30 vs 1.87 +/- 0.56 P < 0.05) by paired t-test. Compared to the total controls and the paired controls, decreases were seen in markers of bone formation; bone alkaline phosphatase, (72 +/- 30 vs 126 +/- 43 P < 0.001), osteocalcin (10.7 +/- 3.4 vs 13.1 +/- 2.0 P < 0.05) and procollagen type I carboxyterminal propeptide. No differences were seen in the bone resorption markers tartrate resistant acid phosphatase and urine Ca/Cr. The changes noted could not be related after age correction to serum phenylalanine levels, protein intake, or mineral intakes. It is unclear whether deficits in bone mineralization relate to the disease process itself or its treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828633     DOI: 10.1007/pl00014234

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  ROENTGENOLOGIC BONE CHANGES IN PHENYLKETONURIA. RELATION TO DIETARY PHENYLALANINE AND SERUM ALKALINE PHOSPHATASE.

Authors:  M M MURDOCH; G H HOLMAN
Journal:  Am J Dis Child       Date:  1964-05

2.  Osteopenia and phenylketonuria.

Authors:  D J Carson; L G Greeves; L E Sweeney; M D Crone
Journal:  Pediatr Radiol       Date:  1990

3.  Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control.

Authors:  M P McMurry; G M Chan; C O Leonard; S L Ernst
Journal:  Am J Clin Nutr       Date:  1992-05       Impact factor: 7.045

4.  Mineral balance in treated phenylketonuric children.

Authors:  R G Wong; P B Acosta; D Jones; R Koch
Journal:  J Am Diet Assoc       Date:  1970-09

5.  Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis.

Authors:  L Hillman; J T Cassidy; L Johnson; D Lee; S H Allen
Journal:  J Pediatr       Date:  1994-06       Impact factor: 4.406

6.  Bony changes of PKU neonates unrelated to phenylalanine levels.

Authors:  R O Fisch; S B Feinberg; S Weisberg; D Day
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

7.  Decreased bone mineral density in children with phenylketonuria.

Authors:  J R Allen; I R Humphries; D L Waters; D C Roberts; A H Lipson; R G Howman-Giles; K J Gaskin
Journal:  Am J Clin Nutr       Date:  1994-02       Impact factor: 7.045

  7 in total
  21 in total

1.  A study of bone turnover markers in prepubertal children with phenylketonuria.

Authors:  Jadwiga Ambroszkiewicz; Joanna Gajewska; Teresa Laskowska-Klita
Journal:  Eur J Pediatr       Date:  2004-01-29       Impact factor: 3.183

2.  Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.

Authors:  S Yannicelli; D M Medeiros
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

3.  Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.

Authors:  Kathryn E Coakley; Eric I Felner; Vin Tangpricha; Peter W F Wilson; Rani H Singh
Journal:  JIMD Rep       Date:  2017-01-28

4.  Bone metabolism and the muscle-bone relationship in children, adolescents and young adults with phenylketonuria.

Authors:  Piotr Adamczyk; Aurelia Morawiec-Knysak; Paweł Płudowski; Beata Banaszak; Jacek Karpe; Wojciech Pluskiewicz
Journal:  J Bone Miner Metab       Date:  2010-08-13       Impact factor: 2.626

5.  Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening.

Authors:  Hironori Nagasaka; Hirokazu Tsukahara; Tomozumi Takatani; Yoshitami Sanayama; Masaki Takayanagi; Toshihiro Ohura; Osamu Sakamoto; Tetsuya Ito; Mika Wada; Makoto Yoshino; Akira Ohtake; Tohru Yorifuji; Satoshi Hirayama; Takashi Miida; Hiroki Fujimoto; Hiroshi Mochizuki; Toshikazu Hattori; Yoshiyuki Okano
Journal:  J Bone Miner Metab       Date:  2011-05-19       Impact factor: 2.626

6.  A New View of Bone Loss in Phenylketonuria.

Authors:  Steven F Dobrowolski; Irina L Tourkova; Cayla R Sudano; Quitterie C Larrouture; Harry C Blair
Journal:  Organogenesis       Date:  2021-08-25       Impact factor: 2.316

7.  Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.

Authors:  Ilaria Roato; Francesco Porta; Alessandro Mussa; Lucia D'Amico; Ludovica Fiore; Davide Garelli; Marco Spada; Riccardo Ferracini
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 8.  A systematic review of bone mineral density and fractures in phenylketonuria.

Authors:  Karen E Hansen; Denise Ney
Journal:  J Inherit Metab Dis       Date:  2014-07-09       Impact factor: 4.982

9.  A long-term study of bone mineral density in patients with phenylketonuria under diet therapy.

Authors:  Hala M Koura; Nagwa Abdallah Ismail; Ashraf F Kamel; Azza M Ahmed; Amal Saad-Hussein; Laila K Effat
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

10.  A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.

Authors:  Anne Daly; Wolfgang Högler; Nicola Crabtree; Nick Shaw; Sharon Evans; Alex Pinto; Richard Jackson; Catherine Ashmore; Júlio C Rocha; Boyd J Strauss; Gisela Wilcox; William D Fraser; Jonathan C Y Tang; Anita MacDonald
Journal:  Nutrients       Date:  2021-06-17       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.